時本美 鳳凰概念食品
時本美 鳳凰概念食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
règlement (UE) 2022/63. Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| TRANS-RESVERATROL | TRANS-RESVERATROL | Not identified |
| PIPERINE | PIPERINE | Pipérine |
| D-SORBITOL | D-SORBITOL | Not identified |
| MICROCRYSTALLINE α-CELLULOSE | MICROCRYSTALLINE α-CELLULOSE | Not identified |
| HYDROXYPROPYL CELLULOSE | HYDROXYPROPYL CELLULOSE | Not identified |
| SILICON DIOXIDE | SILICON DIOXIDE | Not identified |
| CALCIUM STEARATE | CALCIUM STEARATE | Not identified |
| SHELLAC | SHELLAC | Not identified |
| CARNAUBA WAX | CARNAUBA WAX | Not identified |
| GELATIN | GELATIN | Not identified |
| GLYCEROL | GLYCEROL | Glycérol |
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | Not identified |
| TARTRAZINE | TARTRAZINE | Not identified |
| SUNSET YELLOW FCF | SUNSET YELLOW FCF | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- 1139041151
- Chinese name
- 時本美 鳳凰概念食品
- English name
- KIRAKIRA KINIRO
- Type
- Imported tablets and capsules
- Published status
- Status not provided in this export; the validity date is shown separately
- Licence holder
- 元嘉生醫股份有限公司
- Registration date
- 2024-07-04
- Published validity end
- 2029-07-04
Original register data
View published fields and their variants
- Product name
- 時本美 鳳凰概念食品
- Active ingredients
- TRANS-RESVERATROL;;PIPERINE;;D-SORBITOL;;MICROCRYSTALLINE α-CELLULOSE;;HYDROXYPROPYL CELLULOSE;;SILICON DIOXIDE;;CALCIUM STEARATE;;SHELLAC;;CARNAUBA WAX;;GELATIN;;GLYCEROL;;TITANIUM DIOXIDE;;TARTRAZINE;;SUNSET YELLOW FCF;;
- Valid until
- 1180704
- Registration number
- 1139041151
- Licence holder
- 元嘉生醫股份有限公司
- Registration date
- 1130704
- Published reference
- DHC0B390411512
- Published English name
- KIRAKIRA KINIRO
Official source
View the official register, number 1139041151
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
Open Government Data License, version 1.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- PIPERINE
Read the warning, when it applies and the studies cited
BLACK/WHITE PEPPER - PIPER NIGRUM
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications or any other health products, as black/white pepper/piperine may alter their effectiveness (Han 2011; Srinivasan 2007; Khajuria et al. 2002; Bano et al. 1991).1
Sources cited by Health Canada (4)
- Bano G, Raina RK, Zutshi U, Bedi KL, Johri RK, Sharma SC. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. European Journal of Pharmacology 1991;41(6):615-7. PubMed
- Han HK. The effects of black pepper on the intestinal absorption and hepatic metabolism of drugs. Expert Opinion on Drug Metabolism & Toxicology 2011;7(6):721-729. PubMed Review article
- Khajuria A, Thusu N, Zutshi U. Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics. Phytomedicine 2002;9(3):224-31. PubMed
- Srinivasan K. Black Pepper and its pungent principle-piperine: a review of diverse physiological effects. Critical Reviews in Food Science and Nutrition 2007;47(8):735-748. PubMed Review article
1Note: At subtherapeutic quantities, the risk statement regarding the alteration of effectiveness is not required for products providing 25 mg or less Piper nigrum fruit per day for Class II and III applications.
Condition of application: Improve digestion.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Vermifuge/anthelmintic.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or persist for more than 2 weeks.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.